Upgrade to SI Premium - Free Trial

Omeros (OMER) Issues Positive Update for OMS721 in AMD

November 5, 2013 7:12 AM
Omeros Corporation (Nasdaq: OMER) announced positive data using OMS721, the lead human monoclonal antibody in Omeros' mannan-binding lectin-associated serine protease-2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles